Mycophenolate mofetil Completed Phase 3 Trials for Glomerulonephritis, Membranous / Glomerulosclerosis, Focal Segmental Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00404833Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental